# GMO Trust on behalf of its series GMO U.S. Opportunistic Value Fund — Form D

GMO Trust on behalf of its series GMO U.S. Opportunistic Value Fund of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2023-03-07. $299.2M was reported sold. Industry: Pooled Investment Fund.

## Offering

- Filed: 2023-03-07
- Form: D
- Accession: 0001104659-23-029455
- Industry: Pooled Investment Fund
- Exemptions: 06b
- Amount sold: $299.2M
- Minimum investment: $5.0M
- Investors: 6
- Date of first sale: 2022-12-13
- SEC file number: 021-475096

## Issuer

- Name: GMO Trust on behalf of its series GMO U.S. Opportunistic Value Fund
- CIK: 0001963416
- Entity type: Business Trust
- Jurisdiction: MASSACHUSETTS
- Incorporated: 2022
- Address: 40 ROWES WHARF, BOSTON, MA, 02110
- Phone: 617-330-7500

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Paul Braverman | Director | Boston, MA |
| Donald Glazer | Director | Boston, MA |
| Dina Santoro | Director | Boston, MA |
| Peter Tufano | Director | Boston, MA |
| Dina Santoro | Executive Officer | Boston, MA |

## More

- [CIK 1963416 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1963416&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001104659-23-029455.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.